Works matching IS 10837159 AND DT 2018 AND VI 23 AND IP 3


Results: 19
    1
    2
    3
    4
    5

    Characteristics of Real‐World Metastatic Non‐Small Cell Lung Cancer Patients Treated with Nivolumab and Pembrolizumab During the Year Following Approval.

    Published in:
    Oncologist, 2018, v. 23, n. 3, p. 328, doi. 10.1634/theoncologist.2017-0353
    By:
    • Khozin, Sean;
    • Abernethy, Amy P.;
    • Nussbaum, Nathan C.;
    • Zhi, Jizu;
    • Curtis, Melissa D.;
    • Tucker, Melisa;
    • Lee, Shannon E.;
    • Light, David E.;
    • Gossai, Anala;
    • Sorg, Rachael A.;
    • Torres, Aracelis Z.;
    • Patel, Payal;
    • Blumenthal, Gideon Michael;
    • Pazdur, Richard
    Publication type:
    Article
    6
    7
    8
    9
    10

    Clinical Activity of Pazopanib in Patients with Advanced Desmoplastic Small Round Cell Tumor.

    Published in:
    Oncologist, 2018, v. 23, n. 3, p. 360, doi. 10.1634/theoncologist.2017-0408
    By:
    • Menegaz, Brian A.;
    • Cuglievan, Branko;
    • Benson, Jalen;
    • Camacho, Pamela;
    • Lamhamedi‐Cherradi, Salah‐Eddine;
    • Leung, Cheuk Hong;
    • Warneke, Carla L.;
    • Huh, Winston;
    • Subbiah, Vivek;
    • Benjamin, Robert S.;
    • Patel, Shreyaskumar;
    • Daw, Najat;
    • Hayes‐Jordan, Andrea;
    • Ludwig, Joseph A.
    Publication type:
    Article
    11
    12

    FDA Benefit‐Risk Assessment of Osimertinib for the Treatment of Metastatic Non‐Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor T790M Mutation.

    Published in:
    Oncologist, 2018, v. 23, n. 3, p. 353, doi. 10.1634/theoncologist.2017-0425
    By:
    • Odogwu, Lauretta;
    • Mathieu, Luckson;
    • Goldberg, Kirsten B.;
    • Blumenthal, Gideon M.;
    • Larkins, Erin;
    • Fiero, Mallorie H.;
    • Rodriguez, Lisa;
    • Bijwaard, Karen;
    • Lee, Eunice Y.;
    • Philip, Reena;
    • Fan, Ingrid;
    • Donoghue, Martha;
    • Keegan, Patricia;
    • McKee, Amy;
    • Pazdur, Richard
    Publication type:
    Article
    13
    14
    15
    16

    First Prospective Multicenter Italian Study on the Impact of the 21‐Gene Recurrence Score in Adjuvant Clinical Decisions for Patients with ER Positive/HER2 Negative Breast Cancer.

    Published in:
    Oncologist, 2018, v. 23, n. 3, p. 297, doi. 10.1634/theoncologist.2017-0322
    By:
    • Dieci, Maria Vittoria;
    • Guarneri, Valentina;
    • Giarratano, Tommaso;
    • Mion, Marta;
    • Tortora, Giampaolo;
    • De Rossi, Costanza;
    • Gori, Stefania;
    • Oliani, Cristina;
    • Merlini, Laura;
    • Pasini, Felice;
    • Bonciarelli, Giorgio;
    • Griguolo, Gaia;
    • Orvieto, Enrico;
    • Michieletto, Silvia;
    • Saibene, Tania;
    • Del Bianco, Paola;
    • De Salvo, Gian Luca;
    • Conte, PierFranco
    Publication type:
    Article
    17
    18
    19